Automated Insulin Delivery for Inpatients With Dysglycemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT06418880

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06418880
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06418880. Randomized; no masking; primary purpose treatment. Start 2025-01-22 (actual); primary completion 2025-10-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Automated Insulin Delivery for Inpatients With Dysglycemia
Acronym
AIDING
Condition
Type 1 Diabetes
Intervention (Device)
AID system with Remote Real-Time CGM
Intervention (Combination product)
Standard of Care Insulin Therapy + CGM
Lead sponsor
Emory University (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct06418880
Content hash
622d910d703339ffc1f2c9e1d568dc1610c9e2b1624fa1bb7ca65348f9904359